PAO1 CARDIORENAL EFFECTS AND COSTS OF COX-2 INHIBITORS IN A MANAGED CARE ORGANIZATION
May 1, 2002, 00:00 AM
10.1016/S1098-3015(10)60953-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)60953-9/fulltext
Section Title :
Section Order :
141
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)60953-9&doi=10.1016/S1098-3015(10)60953-9